KY-1055

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameKY-1055

Drug Alias NameKY-1055

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Programmed death-ligand 1Anti-Inducible T-cell costimulator

TargetsProgrammed death-ligand 1Inducible T-cell costimulator

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKymab Ltd

China Registration ClassN/A

Develop Information

Active CompaniesKymab Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A